Sinil Pharmaceutical (Korea) Today
| 012790 Stock | KRW 6,600 10.00 0.15% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sinil Pharmaceutical is trading at 6600.00 as of the 25th of November 2024, a 0.15 percent increase since the beginning of the trading day. The stock's open price was 6590.0. Sinil Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sinil Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of December 2023 and ending today, the 25th of November 2024. Click here to learn more.
Sinil Pharmaceutical Co., Ltd. manufactures, markets, and sells pharmaceutical products in South Korea. Sinil Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea. Shinil Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.. The company has 7.5 M outstanding shares. More on Sinil Pharmaceutical Co
Moving against Sinil Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sinil Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sinil Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sinil Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Jae Hong |
| Business Concentration | Pharmaceuticals, Healthcare (View all Sectors) |
Sinil Pharmaceutical Co (012790) is traded on KOSDAQ in Korea and employs 13 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 62.74 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sinil Pharmaceutical's market, we take the total number of its shares issued and multiply it by Sinil Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sinil Pharmaceutical operates under Healthcare sector and is part of Pharmaceuticals industry. The entity has 7.5 M outstanding shares.
Sinil Pharmaceutical Co has accumulated about 7.31 B in cash with 11.16 B of positive cash flow from operations.
Check Sinil Pharmaceutical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Sinil Pharmaceutical is W62.74 Billion. Sinil Pharmaceutical maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Sinil Ownership Details
Sinil Pharmaceutical Risk Profiles
Although Sinil Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Sinil Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.2 | |||
| Standard Deviation | 1.62 | |||
| Variance | 2.62 | |||
| Risk Adjusted Performance | (0.10) |
Sinil Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sinil Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Sinil Pharmaceutical Corporate Directors
Other Information on Investing in Sinil Stock
Sinil Pharmaceutical financial ratios help investors to determine whether Sinil Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sinil with respect to the benefits of owning Sinil Pharmaceutical security.